161 related articles for article (PubMed ID: 24055412)
21. Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120.
Ifran A; Haşimi A; Kaptan K; Nevruz O; Beyan C; Erbil K
Transfus Apher Sci; 2005 Oct; 33(2):87-90. PubMed ID: 16139569
[TBL] [Abstract][Full Text] [Related]
22. Changes in hematological parameters post plateletpheresis: Single center study from North India.
Rajput S; Makroo RN; Chowdhry M; Thakur UK
Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
[TBL] [Abstract][Full Text] [Related]
23. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of the Trima Accel cell separator in the double dose plateletpheresis.
Keklik M; Korkmaz S; Kalan U; Sarikoc M; Keklik E
Transfus Apher Sci; 2016 Oct; 55(2):240-242. PubMed ID: 27522105
[TBL] [Abstract][Full Text] [Related]
25. Studies on some coagulation parameters and platelet function in leuko and platelet-apheresed donors.
Garelli S; Valbonesi M; Mosconi L; Cattaneo A
Riv Emoter Immunoematol; 1980; 27(3-4):218-24. PubMed ID: 7339851
[No Abstract] [Full Text] [Related]
26. Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors.
Koch HM; Angerer J; Drexler H; Eckstein R; Weisbach V
Int J Hyg Environ Health; 2005; 208(6):489-98. PubMed ID: 16325559
[TBL] [Abstract][Full Text] [Related]
27. Influence of multicomponent apheresis on donors' haematological and coagulation parameters, iron storage and platelet function.
Macher S; Sipurzynski-Budraβ S; Rosskopf K; Semmelrock M; Prüller F; Griesbacher A; Lanzer G; Schallmoser K
Vox Sang; 2012 Oct; 103(3):194-200. PubMed ID: 22471611
[TBL] [Abstract][Full Text] [Related]
28. The relationship of platelet yield, donor's characteristic and apheresis instruments in China.
Yin G; Xu J; Shen Z; Wang Y; Zhu F; Lv H
Transfus Apher Sci; 2013 Dec; 49(3):608-12. PubMed ID: 23978555
[TBL] [Abstract][Full Text] [Related]
29. [Plateletpheresis with the new cell separator A 201 (Baxter)].
Luboldt W; Moog R
Beitr Infusionsther; 1991; 28():195-200. PubMed ID: 1725618
[TBL] [Abstract][Full Text] [Related]
30. A prospective quality evaluation of single donor platelets (SDP) - an experience of a tertiary healthcare center in India.
Pandey P; Tiwari AK; Sharma J; Singh MB; Dixit S; Raina V
Transfus Apher Sci; 2012 Apr; 46(2):163-7. PubMed ID: 22365925
[TBL] [Abstract][Full Text] [Related]
31. Effective cell support by repeat plateletpheresis of related donors on the IBM 2997 cell separator.
Langley JW; Spiva D; Hendren D; Orrell J
Am J Clin Pathol; 1981 Aug; 76(2):148-54. PubMed ID: 7270495
[TBL] [Abstract][Full Text] [Related]
32. Plateletpheresis-associated lymphopenia in frequent platelet donors.
Gansner JM; Rahmani M; Jonsson AH; Fortin BM; Brimah I; Ellis M; Smeland-Wagman R; Li ZJ; Schenkel JM; Brenner MB; Yefidoff-Freedman R; Sloan SR; Berliner N; Issa NC; Baden LR; Longo DL; Wesemann DR; Neuberg D; Rao DA; Kaufman RM
Blood; 2019 Feb; 133(6):605-614. PubMed ID: 30429159
[TBL] [Abstract][Full Text] [Related]
33. Rates of vaso-vagal reactions among first time teenaged whole blood, double red cell, and plateletpheresis donors.
Reiss RF; Harkin R; Lessig M; Mascari J
Ann Clin Lab Sci; 2009; 39(2):138-43. PubMed ID: 19429799
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
[TBL] [Abstract][Full Text] [Related]
35. Plateletpheresis does not cause long-standing platelet-derived growth factor release into the donor blood.
Zimmermann R; Loew D; Weisbach V; Strasser E; Ringwald J; Zingsem J; Eckstein R
Transfusion; 2005 Mar; 45(3):414-9. PubMed ID: 15752160
[TBL] [Abstract][Full Text] [Related]
36. Feasibility and safety of triple dose platelet collection by apheresis.
Moog R
J Clin Apher; 2009; 24(6):238-40. PubMed ID: 19908304
[TBL] [Abstract][Full Text] [Related]
37. How to stabilize the level of ionized calcium and citrate during plateletpheresis.
Farrokhi P; Farahmand H; Bismuth A; Suarez C; Ducot B; Gillon MC; Debat P; Laskowski P; Pinon F
Vox Sang; 1998; 74(1):7-12. PubMed ID: 9481853
[TBL] [Abstract][Full Text] [Related]
38. Assessing the performance of a plateletpheresis unit at a tertiary-care academic medical center in Mexico: A 6-year experience.
Jaime-Pérez JC; Beltrán-López AL; Alvarado-Navarro DM; Espinoza-Mares M; Ancer-Rodríguez J; Gómez-Almaguer D
J Clin Apher; 2021 Dec; 36(6):808-814. PubMed ID: 34411330
[TBL] [Abstract][Full Text] [Related]
39. [Alterations in coagulation in patients during transplant conditioning regimen before allogeneic hematopoietic stem cell transplantation].
Jiang Q; Huang XJ; Liu KY; Chen H; Chen YH; Gao ZY; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):173-7. PubMed ID: 16792919
[TBL] [Abstract][Full Text] [Related]
40. Comparison of plateletpheresis with two different cell separators using 100 identical donors.
Wiesneth M; Freudenberg J; Platow S; Kalinova J; Vogel M; Kubanek B
Beitr Infusionsther; 1991; 28():201-3. PubMed ID: 1725619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
